- dott.ssa Marina Scavini
- dott.ssa Amelia Caretto, dott.ssa Alice Burini
Trial comparing the effect and safety of insulin degludec once daily with insulin detemir
once daily or twice daily both in combination with insulin aspart 2-4 times daily with meals in
pregnant women with type 1 diabetes mellitus.
This is a randomised (1:1), open-label, parallel, multi-centre, multi-national, treat-to-target, active
- Type 1 diabetes
- Phase 3
A trial comparing the effect and safety of insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes.